Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.
- DOI
- 10.1111/hae.13953
- Published
- 2020 May
- Container
- Haemophilia : the official journal of the World Federation of Hemophilia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/hae.13953,
title = {Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.},
author = {Nolan B and Mahlangu J and Pabinger I and Young G and Konkle BA and Barnes C and Nogami K and Santagostino E and Pasi KJ and Khoo L and Winding B and Yuan H and Fruebis J and Rudin D and Oldenburg J},
year = {2020},
journal = {Haemophilia : the official journal of the World Federation of Hemophilia},
doi = {10.1111/hae.13953},
url = {https://doi.org/10.1111/hae.13953}
}RIS
TY - JOUR TI - Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study. AU - Nolan B AU - Mahlangu J AU - Pabinger I AU - Young G AU - Konkle BA AU - Barnes C AU - Nogami K AU - Santagostino E AU - Pasi KJ AU - Khoo L AU - Winding B AU - Yuan H AU - Fruebis J AU - Rudin D AU - Oldenburg J PY - 2020 JO - Haemophilia : the official journal of the World Federation of Hemophilia DO - 10.1111/hae.13953 UR - https://doi.org/10.1111/hae.13953 ER -
APA
B, N., J, M., I, P., G, Y., BA, K., C, B., K, N., E, S., KJ, P., L, K., B, W., H, Y., J, F., D, R., & J, O. (2020). Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.. Haemophilia : the official journal of the World Federation of Hemophilia. https://doi.org/10.1111/hae.13953
Source records
- pubmed · retrieved 2026-09-26T20:43:42.129Z